Ketamine therapy for teen PTSD: early safety trial halted
NCT ID NCT06378528
First seen Jun 27, 2026 · Last updated Jun 27, 2026
Summary
This early-phase study tested whether ketamine-assisted psychotherapy is safe and feasible for adolescents aged 15-17 with severe posttraumatic stress disorder (PTSD). Five participants were to receive three intravenous ketamine doses paired with therapy sessions over six weeks. The study is currently suspended, and its main goal was to check for side effects and whether teens could stick with the treatment plan.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for POSTTRAUMATIC STRESS DISORDER are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
University of Wisconsin
Madison, Wisconsin, 53705, United States
More trials for these conditions
Other studies related to the condition(s) this trial covers.
- Brain-training game aims to sharpen thinking and ease PTSD in veterans
- Brain zaps guided by MRI aim to quiet PTSD symptoms
- Could a simple writing therapy ease PTSD in autistic adults?
- Could a Nurse-Led support program ease Families' trauma after ICU?
- Brief writing therapy could ease PTSD in people recovering from substance use
- Can a 4-session talk therapy prevent PTSD after a burn injury?